Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases
Open accessThe DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Abstract
Over the past two decades, the female hormone 17β-estradiol (estrogen) has emerged as an important contributor to energy homeostasis in both males and females. Early clinical evidence involved the observation that men lacking estrogen synthesis secondary to mutations in aromatase—the enzyme that converts androgen to estrogen—or men harboring estrogen resistance secondary to mutation of the estrogen receptor (ER)α, develop visceral obesity, insulin resistance, and/or glucose intolerance (1,2). As an experimental confirmation, it was observed that elimination of the aromatase or ERα genes in male and female mice produced the same metabolic syndrome as in humans (3,4). Thus, it is reasonable to assume that although men have lower circulating estrogen concentrations than premenopausal women, aromatization of circulating androgen to estrogen in target metabolic tissues equilibrates cellular estrogen concentrations, and ER activation is critical in both sexes in promoting fuel homeostasis (5). This is consistent with the paradigm that estrogen functions as a circulating hormone in premenopausal women. Conversely, in men and in postmenopausal women—in whom estrogen concentrations are low—estradiol does not function as a hormone; instead, it is synthesized in extragonadal sites such as breast, brain, bone, and fat where it acts locally as a paracrine or intracrine factor (6). Thus, in men and in postmenopausal women, the driver of estrogen action is not circulating estrogens; rather, it depends on estrogen biosynthesis from a circulating source of androgenic precursors such as testosterone. A logical consequence …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“EST is expressed in adipose tissue and reduces adipocyte size, although an overexpression of EST in sc and visceral adipose tissue may induce insulin resistance.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471 · cited 1×
“Early clinical evidence involved the observation that men lacking estrogen synthesis secondary to mutations in aromatase—the enzyme that converts androgen to estrogen—or men harboring estrogen resistance secondary to mutation of the estrogen receptor (ER)a, develop visceral obesity, insulin resistance, and/or glucose…”
BackgroundMorishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Increased adipose tissue in male and female estrogen receptor-α knockout mice
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12729 · Cited by 1,282
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
Jones, M. E. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., Proietto, J., Oz, O. K., Leury, B. J., Robertson, K. M., Yao, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12735 · Cited by 729
Distinct Hypothalamic Neurons Mediate Estrogenic Effects on Energy Homeostasis and Reproduction
Xu, Y., Nedungadi, T. P., Zhu, L., Sobhani, N., Irani, B. G., Davis, K. E., Zhang, X., Zou, F., Gent, L. M., Hahner, L. D., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.009 · Cited by 597 · cited 1×
“Thus, elimination of ERa in hypothalamic neurons impairs energy homeostasis (19), knockout of ERa in macrophages produces a metabolic syndrome and accelerates atherosclerosis (20), and null deletion of ERa in pancreatic islets impairs insulin biosynthesis and b-cell survival and predisposes to glucolipotoxicity (13–17…”
BackgroundLe May, C., Chu, K., Hu, M., Ortega, C. S., Simpson, E. R., Korach, K. S., Tsai, M.-J., & Mauvais-Jarvis, F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602956103 · Cited by 498
Self-citationEstrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice
Riant, E., Waget, A., Cogo, H., Arnal, J.-F., Burcelin, R., & Gourdy, P. (2009) · Endocrinology · doi:10.1210/en.2008-0971 · Cited by 421 · cited 1×
“Consistent with this possibility is the observation that estrogen treatment leading to high blood concentrations produces WAT inflammation even in females (18).”
BackgroundKester, M. H. A., Bulduk, S., Tibboel, D., Meinl, W., Glatt, H. R., Falany, C. N., Coughtrie, M. W. H., Bergman, Å., Safe, S. H., Kuiper, G. G. J. M., et al. (2000) · Endocrinology · doi:10.1210/en.141.5.1897 · Cited by 383
Mauvais-Jarvis, F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.10.002 · Cited by 335 · cited 1×
“Thus, it is reasonable to assume that although men have lower circulating estrogen concentrations than premenopausal women, aromatization of circulating androgen to estrogen in target metabolic tissues equilibrates cellular estrogen concentrations, and ER activation is critical in both sexes in promoting fuel homeosta…”
BackgroundSelf-citationEstrogen—the Good, the Bad, and the Unexpected
Simpson, E. R., Misso, M., Hewitt, K. N., Hill, R. A., Boon, W. C., Jones, M. E., Kovacic, A., Zhou, J., & Clyne, C. D. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0020 · Cited by 266 · cited 1×
“Conversely, in men and in postmenopausal women—in whom estrogen concentrations are low—estradiol does not function as a hormone; instead, it is synthesized in extragonadal sites such as breast, brain, bone, and fat where it acts locally as a paracrine or intracrine factor (6).”
Background
Cited by
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
Self-citationSex differences in metabolic homeostasis, diabetes, and obesity
Mauvais-Jarvis, F. (2015) · Biology of Sex Differences · doi:10.1186/s13293-015-0033-y · Cited by 626
Self-citationEstrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
Sex differences in energy metabolism: natural selection, mechanisms and consequences
Mauvais‐Jarvis, F. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00781-2 · Cited by 185
Self-citationBeneficial and Adverse Effects of Testosterone on the Cardiovascular System in Men
Ruige, J. B., Ouwens, D. M., & Kaufman, J.-M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1970 · Cited by 100
Metadata
- Authors
- Mauvais-Jarvis, F.
- Affiliations
- Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Comprehensive Center on Obesity, Northwestern University Feinberg School of Medicine, Chicago, Illinois
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-05-14
- Volume
- 61
- Issue
- 6
- Pages
- 1353-1354
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3357281
- OpenAlex
- W2118759932
- Cited by
- 18
- References
- 22
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 2 · 2020: 1 · 2018: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 5
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- March of Dimes Foundation
- American Heart Association (11IRG5570010)
- National Institutes of Health (HD044405)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK074970)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- estrogen sulfotransferase, estradiol, aromatase, estrogen receptor alpha, energy homeostasis, visceral obesity, insulin resistance, impaired glucose tolerance, metabolic syndrome
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Female, Insulin Resistance, Liver, Male, Sulfotransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases. https://app.cochat.ai/papers/10.2337/db12-0357
- The paper
- Mauvais-Jarvis, F. (2012). Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases. Diabetes. https://doi.org/10.2337/db12-0357
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.